Results 81 to 90 of about 1,356,506 (200)
ABSTRACT Objective To evaluate the safety, short‐term and mid‐term occlusion performance of the Absnow fully biodegradable atrial septal occluder in pediatric patients. Background The Absnow Occluder, an innovative fully biodegradable closure for ASD, has shown its safety and effectiveness in initial animal studies and preclinical trials.
Shiqiang Fan +7 more
wiley +1 more source
Objective: An atrial septal defect (ASD) is one of the most common congenital heart defects and is associated with an increased risk of atrial arrhythmias.
Ayan Abdrakhmanov +3 more
doaj +1 more source
Background To describe complications associated with Amplatzer septal occluders in a patient with Marfan syndrome Case presentation A nine-year-old boy with Marfan syndrome and a 22 mm atrial septal defect (ASD) was treated successfully by interventional
Schlensak Christian +2 more
doaj +1 more source
Circular Loop Ligation for Securing Endobronchial Valve in the Treatment of Bronchial Stump Fistula
Background Bronchial stump fistula (BSF), which is located on the bronchial stump following pulmonary resection, represents a distinct subtype of bronchopleural fistula (BPF). Although the endobronchial valve (EBV) has been used to treat BPF, few clinical studies involve BSF occluded by EBV because the abnormal bronchial stump makes EBV implantation ...
Liping Wang +6 more
wiley +1 more source
Cobrahead deformity is a known (but uncommon) phenomenon associated with the left atrial disc of the AMPLATZER or Occlutech Figulla septal occluder device during percutaneous transcatheter atrial septal defect closure.
ŞAHİN, TAYFUN +2 more
core +1 more source
Background Traditional occluders for atrial septal defect have 2 drawbacks: incomplete endothelialization and difficulty in achieving atrial septum puncture post implantation. The novel occluder ReAces was designed to address these 2 clinical pain points.
Yanxing Fang +9 more
doaj +1 more source
Objective This study was designed to first evaluate the histological compatibility of the split occluder in preclinical animal models, followed by clinical validation of its procedural feasibility and occlusion effectiveness in a first‐in‐human trial cohort. Methods Eight healthy labrador retrievers were selected for this study.
Mingfei Li +8 more
wiley +1 more source
Right aortic arch (RAA) associated with isolated atrial septal defect (ASD) is very rare. We report successful closure of ASD associated with RAA using a 26-mm atrial septal occluder in a 30-year-old male patient.
Nageswara Rao Koneti +3 more
doaj +1 more source
Aims: To evaluate the safety and efficacy of the new Cera septal occluder (CSO) for atrial septal defect (ASD) closure as compared to the AMPLATZER Septal Occluder (ASO)
Meric, Murat +7 more
core +1 more source
Background: Atrial deptal defect device closure has become the preferred method in the treatment of atrial septal defect. We aim to study the in-hospital complications of atrial septal defect device closure procedure.
Chandra Mani Adhikari +4 more
doaj +1 more source

